Wonder: I'm just learning the basics and make a clue of it. Hemosep is a blood management procedure.
Hemosep is a device that recently and successfully broke in the market of blood salvage.
Hemosep seems to have taken over a market share from Haemonetics with this machine. Haemonetics has been one of the largest supplier of blood management technologies to this point - they developed one of the first cell savers back in the early 70s.
Hemosep boasts that it is small, easy to transport and use. It is also cost effective making it attractive to places like the Canadian market whose health care system is bolstered with public funds.
However, it also has drawbacks. It can only process one litre of blood at a time*, making it a questionable device for trauma emergencies where a patient loses much more than a litre of blood when they hemorrhage. (*basically, what a Hemosep machine does, is it takes a person's blood and concentrates it and then that concentrated blood is transfused back into the patient. The patient gets all the 'goodies' from their blood without the volume - the volume has already been added to the patient's system with synthetic volume expanders)
At this point, as far as I know, the Hemosep machine has been approved by Health Canada for use in cardiac surgeries and for "other situations". In other words....they will use if for JWs who have no other option than to use the machine for "off-label" use - to try to save their lives when conventional transfusion have been taken off the table as a line of treatment.
I guess time will tell if the Hemosep machine has any safety issues yet to be worked out. It is performing fairly well so far from all indications. But it is a fairly new device that is still, as far as I can tell, in testing stages, especially for procedures other than open heart surgery.